SO
Sobi
Siste kurs
463,20 SEK
22.7.2026
Siste
515,00 SEK
+11.18%
Oppside
3 mnd
515,60 SEK
+11.31%
Oppside
SOBI
3 mnd+11,31%10 kursmål
6 mnd+11,01%11 kursmål
1 år+9,85%12 kursmål
Maks-12,08%26 kursmål
Deutsche BankSEBPareto SecuritiesHC WainwrightDanske BankDNB CarnegieBerenbergExane BNP ParibasBarclaysHandelsbanken
HelsevesenDrug Manufacturers—Specialty & Generic
Om selskapet
Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia
Tre måneders konsensus
Konsensus
515,60 SEK
Oppside
+11,31%
Siste kurs463,20 SEK
Innsidehandel for Sobi
Ingen innsidehandler for valgt periode.
